NCT06102759View on ClinicalTrials.gov

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

October 10, 2026

Study Completion Date

October 10, 2026

Conditions
Gastric Cancer
Interventions
DRUG

Adebrelimab，Fruquintinib

Adebrelimab，Fruquintinib combined with chemotherapy

Trial Locations (1)

300060

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER